Introduction {#s1}
============

Functional dyspepsia (FD) is manifested by different gastrointestinal (GI) symptoms like gastric fullness, early satiety, nausea and vomiting, belching, bloating, heartburn and epigastric pain. It was previously known as non-ulcer dyspepsia or idiopathic dyspepsia.^[@R1],[@R2]^

The pathophysiology of FD is not well understood, however, some factors like GI motor abnormalities, gastric hypersensitivity, psychosocial factors and *Helicobacter pylori* infection play important role.^[@R2]-[@R4]^

FD is a common public health problem around the world with prevalence rate of 11-30% based on the different definitions of it (Rome criteria I, II, III).^[@R2]^ Although FD is not a life threatening condition, it is accompanied by poor quality of life and experience of various medications and herbs.^[@R5]^ Since there is not yet any verified medical protocol to treat FD, the consumption of medicinal plants is increasing.

The rhizome of ginger (*Zingiber officinale* Roscoe, family Zingiberaceae) is one of the most popular medicinal plants worldwide. It has long been used as a remedy for different diseases including GI ailments like belching, bloating, vomiting, indigestion and constipation.^[@R6],[@R7]^

There are also some scientific evidences regarding its gastro-protective effects like improving the dyspeptic symptoms.^[@R7]-[@R11]^ Moreover, based on the results of some experimental studies ginger treatment seems to inhibit *H. pylori* growth^[@R12]-[@R16]^ and prevent the gastric ulceration.^[@R17]^

However, to the best of our knowledge, the effect of ginger consumption alone (not in combination with other herbs) on *H. pylori* eradication has not yet been assessed in any clinical trial. Accordingly, the present study aimed to assess the effect of ginger powder supplementation on *H. pylori* eradication and improvement of dyspeptic symptoms in patients with *H. pylori* positive FD.

Materials and Methods {#s2}
=====================

Study design and subjects {#s2-1}
-------------------------

The present pilot study was conducted as a before-after clinical trial on patients with *H. pylori* positive FD who were referred to endoscopy unit of Imam Reza hospital (Tabriz, Iran). The exclusion criteria were age under 18 or over 65, clinically diagnosed peptic ulcer during endoscopy, negative urease test, hepatobiliary disease, irritable bowel syndrome and gastric cancer, having severe anorexia or vomiting, history of gastric surgery, taking antibiotics and nonsteroidal anti-inflammatory drugs, smoking and being hypersensitive to ginger.

Accordingly, a total of 15 patients were recruited voluntarily of more than 80 subjects who were initially assessed ([Figure 1](#F1){ref-type="fig"}).
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Intervention {#s2-2}
------------

Dried rhizomes of ginger (*Z. officinale* Roscoe, Chinese yellow ginger) were purchased from a local market in Tabriz. The ginger rhizomes were finely ground and then prepared as tablets containing 1-g ginger powder in each (Pharmaceutics laboratory, Faculty of Pharmacy, Tabriz University of Medical Science). The tablets were placed in the identical bottles. Subjects were asked to take 3 tablets per day with meals for 4 weeks.

Assessments {#s2-3}
-----------

Dyspepsia symptoms were asked before and after the intervention using a questionnaire based on the symptoms of Rome III criteria, including gastric fullness, early satiety, nausea, vomiting, belching, epigastric pain and heartburn which were graded through the visual analog scales (0--10 scores). Moreover, *H. pylori* eradication assessment after ginger treatment was performed by the stool antigen test (HpSAg) in an accredited laboratory since it was impossible to do the endoscopy (rapid urease test) again at the end of intervention. It should be mentioned that HpSAg has \>95% sensitivity, \>94% specificity, and correlation to endoscopy of 95.5%.^[@R18]^

Statistical analysis {#s2-4}
--------------------

Data were analyzed using SPSS software, version 21.0 (IBM Corp., Armonk, NY, USA). Results were reported as mean (SD) and median (IQR). The eradication rate of *H. pylori* was assessed using the chi-square and McNemar tests. The Wilcoxon signed rank test was also used to assess the differences of GI symptoms before and after ginger supplementation. The significance level was set at *P* = 0.05.

Results {#s3}
=======

The baseline characteristics of the participants are shown in [Table 1](#T1){ref-type="table"}. According to [Table 2](#T2){ref-type="table"}, after 4 weeks of ginger supplementation the eradication rate of *H. pylori* was 53.3 % which was statistically significant (*P *= 0.019) and the eradication rate was eight to one based on the presented odds ratio (95% CI).

###### Basic characteristics of study subjects (n = 15)

  ---------------- ---------------
                   **Mean ± SD**
  Age (y)          42.20 (16.83)
  Sex, No. (%)     
  Men              5 (33.3 %)
  Women            10 (66.7%)
  Weight (kg)      69.07 (14.35)
  Height (cm)      163.47 (8.78)
  BMI (kg/cm^2^)   26.04 (6.12)
  ---------------- ---------------

###### The eradication rate of *H. pylori* after ginger supplementation in patients with functional dyspepsia

  -------- ------------------------------ ------------------------------ ----------------------- -------------------
           ***H. pylori*** **positive**   ***H. pylori*** **negative**   ***P*** **value** ^a^   **OR (95% CI)**
  Before   15                             0                                                      
  After    7                              8                              0.019                   8 (1.07 -357.14).
  -------- ------------------------------ ------------------------------ ----------------------- -------------------

^a^Based on the McNemar test.

Ginger supplementation was also accompanied by some improvements in dyspepsia symptoms. In the present study, gastric fullness, nausea, belching and gastric pain were more prevalent than other symptoms in patients with FD. Regarding the non-parametric feature of dyspepsia symptoms' scores, the median and IQR (25th, 75th percentiles) was presented for each variable in [Table 3](#T3){ref-type="table"}. Moreover, the mean (SD) was also reported for better understanding of changes. Based on the Wilcoxon signed rank test, there were significant changes in gastric fullness (*P *= 0.018), early satiety (*P *= 0.039), nausea (*P *= 0.018), belching (*P *= 0.016), gastric pain (*P *= 0.003) and gastric burn (*P *= 0.039) scores after ginger consumption.

###### Comparison of the dyspepsia symptoms before and after ginger supplementation

  ------------------ --------------- ------------------ ----------------------- ------------- -------
                     **Before**      **After**          ***P*** **value** ^a^                 
  **Median (IQR)**   **Mean (SD)**   **Median (IQR)**   **Mean (SD)**                         
  Fullness           1 (1,7)         3.27 (2.89)        1 (1,2)                 1.67 (1.95)   0.018
  Early satiety      1 (1,4)         2.47 (2.58)        1 (1,1)                 1.60 (1.59)   0.039
  Nausea             1 (1,6)         3.13 (2.97)        1 (0,1)                 1.40 (2.06)   0.018
  Vomiting           1 (1,1)         1.47 (1.55)        1 (1,1)                 0.87 (0.35)   0.180
  Belching           2 (1,3)         2.67 (2.61)        1 (0,1)                 1.27 (1.71)   0.016
  Gastric pain       2 (1,4)         2.73 (1.53)        1 (0,1)                 0.73 (0.88)   0.003
  Gastric burn       1 (1,3)         2.40 (2.29)        1 (1,1)                 1.07 (0.88)   0.039
  ------------------ --------------- ------------------ ----------------------- ------------- -------

^a^ Based on Wilcoxon signed rank test.

Discussion {#s4}
==========

*Helicobacter pylori* infection plays important role in the pathogenesis of different gastro-duodenal diseases including gastritis, ulcers and carcinoma.^[@R19]^ Nowadays, the triple or quadruple therapy is used for the eradication of *H. pylori*. However, their eradication rate is not 100% due to resistance to antibiotics and patients' poor compliance.^[@R20]^

According to our results, ginger supplementation caused significant *H. pylori* eradication. Ginger rhizome seems to have anti *H. pylori* activity through its different phenolic compounds (e.g., gingerol, shogaol, zingerone and phenolic acids like gallic acid and cinnamic acid).^[@R12]-[@R15]^ Results of Siddaraju and Dharmesh indicated that a hydrolysed phenolic fraction of ginger had better inhibitory effect against *H. pylori* compared to the ginger free phenolic fraction in vitro.^[@R15]^ Results of Nostro et al showed that the combination of ginger extract and clarithromycin increased the eradication rate of *H. pylori* by their synergic effects.^[@R16]^

In addition, there are some experimental and clinical reports of the anti *H. pylori* effect of multi herbal complexes including ginger.^[@R21],[@R22]^ However, to the best of our knowledge, the anti-*H. pylori* effect of ginger alone has not yet examined in any clinical study.

The ginger extract seems to have the gastro-protective and anti-*H. pylori* effect through some mechanisms including 1) antimicrobial effect by anti-adhesive effect and also suppression of bacterial enzymes and bacterial growth; 2) inhibiting gastric acid secretion through blocking H+, K+- ATPase pomp; 3) gastro-protective effect by increased mucin secretion; 4) anti-oxidative and anti-inflammatory effects which prevent *H. pylori*-induced acute and chronic inflammation.^[@R12],[@R15]-[@R17]^

The other finding of our study was significant changes in most of the dyspepsia symptoms after ginger supplementation which was in consistent with some previous clinical reports.^[@R8]-[@R11]^

Results of Hu et al showed that fasting consumption of 1.2 g ginger powders in patients with FD, significantly increased antral contractions and gastric emptying versus placebo.^[@R10]^

Ginger may have a modulatory effect on intestinal 5-hydroxytryptamine (5-HT; serotonin) receptors which increases GI peristalsis and decrease the food transit time.^[@R8]-[@R11],[@R23]^

The main limitation of the present study was its low sample size. Moreover, it was better to assess the patients' gastric infection at baseline by the stool antigen test (HpSAg) along with the rapid urease test during the endoscopy.

In conclusion, according to our findings, 3 g/d ginger powder supplementation in patients with *H. pylori* positive FD accompanied by significant eradication of *H. pylori* and improvement in dyspeptic symptoms. Therefore, *Z. officinale* can be considered as a complementary therapy for FD. However, due to the small number of clinical trials in this area, further well designed clinical trials are needed to explicitly talk about its effectiveness especially for eradication of *H. pylori*.
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